# Medtech Southeast, Inc. – FDA Inspection, Apr 30, 2009

Source: https://www.keypedia.com/records/fda_inspections/medtech-southeast-inc/1080216b-4e0c-4f72-9fc9-1fcd48293a58
Source feed: FDA_Inspections

> FDA inspection 588497 of Medtech Southeast, Inc., April 30, 2009. Classification: No Action Indicated (NAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 588497
- Company Name: Medtech Southeast, Inc.
- Inspection Date: 2009-04-30
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1067958 - 2018-07-11
- FDA Inspection 981296 - 2016-08-23
- FDA Inspection 887821 - 2014-07-21
- FDA Inspection 712252 - 2011-03-03

Company: https://www.keypedia.com/companies/medtech-southeast-inc/9b732551-08ca-4d86-844f-dff19c556f45

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
